carmustine has been researched along with Lymphoma, Follicular in 24 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Lymphoma, Follicular: Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of 79 evaluable patients, 58 (73%) had follicular lymphoma, 13 (16%) mantle cell lymphoma and 8 (10%) lymphoplasmacytic lymphoma." | 2.73 | Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group. ( Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M, 2007) |
| "Patients with follicular lymphoma (FL) who do not respond to first-line chemotherapy or those who relapse after obtaining a remission have a poor outcome with standard treatment." | 2.69 | Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas. ( Brunet, S; Domingo-Albós, A; López, R; Martino, R; Sierra, J; Sureda, A, 1999) |
| "Despite the fact that follicular lymphomas are both chemo- and radiosensitive, the disease is generally non-curable." | 1.31 | Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. ( Berglund, A; Carlson, K; Enblad, G; Glimelius, B; Hagberg, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bento, L | 1 |
| Boumendil, A | 2 |
| Finel, H | 2 |
| Le Gouill, S | 1 |
| Amorim, S | 1 |
| Monjanel, H | 1 |
| Bouabdallah, R | 2 |
| Bay, JO | 1 |
| Nicolas-Virelizier, E | 1 |
| McQuaker, G | 1 |
| Rossi, G | 1 |
| Johnson, R | 1 |
| Huynh, A | 1 |
| Ceballos, P | 1 |
| Rambaldi, A | 1 |
| Bachy, E | 1 |
| Malladi, R | 1 |
| Orchard, K | 1 |
| Pohlreich, D | 1 |
| Tilly, H | 2 |
| Bonifazi, F | 1 |
| Poiré, X | 1 |
| Guilhot, F | 1 |
| Haenel, A | 1 |
| Crawley, C | 1 |
| Metzner, B | 2 |
| Gribben, J | 2 |
| Russell, NH | 3 |
| Damaj, G | 1 |
| Thomson, K | 2 |
| Dreger, P | 3 |
| Montoto, S | 3 |
| Kothari, J | 1 |
| Peggs, KS | 1 |
| Bird, A | 1 |
| Thomson, KJ | 1 |
| Morris, E | 1 |
| Virchis, AE | 1 |
| Lambert, J | 1 |
| Goldstone, AH | 1 |
| Linch, DC | 1 |
| Ardeshna, KM | 1 |
| Rancea, M | 1 |
| Will, A | 1 |
| Borchmann, P | 1 |
| Monsef, I | 1 |
| Engert, A | 1 |
| Skoetz, N | 1 |
| El-Najjar, I | 1 |
| Luan, JJ | 1 |
| Mohty, M | 1 |
| Colombat, P | 1 |
| Biron, P | 1 |
| Pfreundschuh, M | 1 |
| Cordonnier, C | 1 |
| Sureda, A | 2 |
| Cahn, JY | 1 |
| Vernant, JP | 1 |
| Cook, G | 1 |
| Haynes, AP | 3 |
| Ferrant, A | 1 |
| Caimi, PF | 1 |
| William, BM | 1 |
| Silva Rondon, CH | 1 |
| Fu, P | 1 |
| Cooper, BW | 1 |
| Campagnaro, EL | 1 |
| Gerson, SL | 1 |
| Reese-Koc, J | 1 |
| Fox, R | 1 |
| Creger, RJ | 1 |
| de Lima, M | 1 |
| Lazarus, HM | 1 |
| Derenzini, E | 1 |
| Musuraca, G | 1 |
| Fanti, S | 1 |
| Stefoni, V | 1 |
| Tani, M | 1 |
| Alinari, L | 1 |
| Venturini, F | 1 |
| Gandolfi, L | 1 |
| Baccarani, M | 1 |
| Zinzani, PL | 1 |
| Wang, B | 1 |
| Ren, C | 1 |
| Zhang, W | 1 |
| Ma, X | 1 |
| Xia, B | 1 |
| Sheng, Z | 1 |
| Matthews, J | 1 |
| Greaves, P | 1 |
| Lillington, D | 1 |
| Anderson, D | 1 |
| Gribben, JG | 1 |
| Lister, TA | 1 |
| Pott, C | 1 |
| Müller, TH | 1 |
| Gebauer, W | 1 |
| Casper, J | 1 |
| Kraemer, D | 1 |
| Rosien, B | 1 |
| Schumann-Binarsch, S | 1 |
| Thole, R | 1 |
| Köhne, CH | 1 |
| Blystad, AK | 1 |
| Delabie, J | 1 |
| Kvaløy, S | 1 |
| Holte, H | 1 |
| Vålerhaugen, H | 1 |
| Ikonomou, I | 1 |
| Kvalheim, G | 1 |
| Leger, C | 1 |
| Sabloff, M | 1 |
| McDiarmid, S | 1 |
| Bence-Bruckler, I | 1 |
| Atkins, H | 1 |
| Bredeson, C | 1 |
| Zhang, H | 1 |
| Huebsch, L | 1 |
| Nickenig, C | 1 |
| Dreyling, M | 1 |
| Hoster, E | 1 |
| Ludwig, WD | 1 |
| Dörken, B | 1 |
| Freund, M | 1 |
| Huber, C | 1 |
| Ganser, A | 1 |
| Trümper, L | 1 |
| Forstpointner, R | 1 |
| Unterhalt, M | 1 |
| Hiddemann, W | 1 |
| Krishnan, A | 1 |
| Nademanee, A | 1 |
| Fung, HC | 1 |
| Raubitschek, AA | 1 |
| Molina, A | 1 |
| Yamauchi, D | 1 |
| Rodriguez, R | 1 |
| Spielberger, RT | 1 |
| Falk, P | 1 |
| Palmer, JM | 1 |
| Forman, SJ | 1 |
| Ingram, W | 1 |
| Devereux, S | 1 |
| Das-Gupta, EP | 1 |
| Byrne, JL | 1 |
| Shaw, BE | 1 |
| McMillan, A | 1 |
| Gonzalez, J | 1 |
| Ho, A | 1 |
| Mufti, GJ | 1 |
| Pagliuca, A | 1 |
| Portlock, CS | 1 |
| Bastion, Y | 1 |
| Brice, P | 1 |
| Haioun, C | 1 |
| Sonet, A | 1 |
| Salles, G | 1 |
| Marolleau, JP | 1 |
| Espinouse, D | 1 |
| Reyes, F | 1 |
| Gisselbrecht, C | 1 |
| Coiffier, B | 1 |
| Haas, R | 2 |
| Moos, M | 1 |
| Möhle, R | 1 |
| Döhner, H | 1 |
| Witt, B | 1 |
| Goldschmidt, H | 1 |
| Murea, S | 1 |
| Flentje, M | 1 |
| Wannenmacher, M | 1 |
| Hunstein, W | 1 |
| McQuaker, IG | 1 |
| Iqbal, A | 1 |
| Amigo, ML | 1 |
| del Cañizo, MC | 1 |
| Hernández, JM | 1 |
| Gonzalez, MB | 1 |
| Gutiérrez, N | 1 |
| Mateos, MV | 1 |
| San Miguel, JF | 1 |
| López, R | 1 |
| Martino, R | 1 |
| Brunet, S | 1 |
| Domingo-Albós, A | 1 |
| Sierra, J | 1 |
| Voso, MT | 1 |
| Martin, S | 1 |
| Hohaus, S | 1 |
| Abdallah, A | 1 |
| Schlenk, RF | 1 |
| Ho, AD | 1 |
| Berglund, A | 1 |
| Enblad, G | 1 |
| Carlson, K | 1 |
| Glimelius, B | 1 |
| Hagberg, H | 1 |
| Cao, TM | 1 |
| Horning, S | 1 |
| Negrin, RS | 1 |
| Hu, WW | 1 |
| Johnston, LJ | 1 |
| Taylor, TL | 1 |
| Shizuru, JA | 1 |
| Hoppe, RT | 1 |
| Brown, BW | 1 |
| Blume, KG | 1 |
| Stockerl-Goldstein, KE | 1 |
| Seyfarth, B | 1 |
| Kuse, R | 1 |
| Sonnen, R | 1 |
| Glass, B | 1 |
| Schmitz, N | 1 |
1 review available for carmustine and Lymphoma, Follicular
| Article | Year |
|---|---|
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Top | 2013 |
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Top | 2013 |
6 trials available for carmustine and Lymphoma, Follicular
| Article | Year |
|---|---|
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabin | 2008 |
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabin | 2008 |
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosp | 2006 |
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosp | 2006 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophospham | 2007 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophospham | 2007 |
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Com | 2008 |
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Com | 2008 |
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow Diseases; Carmu | 1996 |
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow Diseases; Carmu | 1996 |
Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease-F | 1999 |
Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease-F | 1999 |
17 other studies available for carmustine and Lymphoma, Follicular
| Article | Year |
|---|---|
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Case-Control Studies; Combi | 2017 |
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Case-Control Studies; Combi | 2017 |
Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine | 2014 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine | 2014 |
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2014 |
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2014 |
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyta | 2015 |
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyta | 2015 |
Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 2013 |
Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 2013 |
Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Combined Mo | 2013 |
Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Combined Mo | 2013 |
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality | 2004 |
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality | 2004 |
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
Topics: Acute Disease; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2008 |
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
Topics: Acute Disease; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2008 |
Management of the indolent non-Hodgkin's lymphomas.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1980 |
Management of the indolent non-Hodgkin's lymphomas.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combinati | 1980 |
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophospham | 1995 |
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophospham | 1995 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Mar | 1996 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Mar | 1996 |
Clonal myelodysplastic cells present in apheresis product before transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromosome Aberrations; Chromosomes, Hum | 1998 |
Clonal myelodysplastic cells present in apheresis product before transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromosome Aberrations; Chromosomes, Hum | 1998 |
Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytara | 2000 |
Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytara | 2000 |
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Co | 2000 |
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Co | 2000 |
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 2001 |
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 2001 |
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine | 2001 |
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine | 2001 |